Rachel K. King

2018

In 2018, Rachel K. King earned a total compensation of $3.2M as President and Chief Executive Officer at GlycoMimetics, a 105% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$286,704
Option Awards$2,350,250
Salary$543,000
Other$5,199
Total$3,185,153

King received $2.4M in option awards, accounting for 74% of the total pay in 2018.

King also received $286.7K in non-equity incentive plan, $543K in salary and $5.2K in other compensation.

Rankings

In 2018, Rachel K. King's compensation ranked 3,621st out of 14,244 executives tracked by ExecPay. In other words, King earned more than 74.6% of executives.

ClassificationRankingPercentile
All
3,621
out of 14,244
75th
Division
Manufacturing
1,341
out of 5,765
77th
Major group
Chemicals And Allied Products
473
out of 2,128
78th
Industry group
Drugs
392
out of 1,817
78th
Industry
Pharmaceutical Preparations
302
out of 1,391
78th
Source: SEC filing on April 10, 2019.

King's colleagues

We found three more compensation records of executives who worked with Rachel K. King at GlycoMimetics in 2018.

2018

Helen Thackray

GlycoMimetics

Chief Medical Officer

2018

John Magnani

GlycoMimetics

Chief Scientific Officer

2018

Brian Hahn

GlycoMimetics

Chief Financial Officer

News

In-depth

You may also like